TD Cowen Sticks to Their Buy Rating for Rocket Pharmaceuticals (RCKT)
TD Cowen analyst Tyler Van Buren maintained a Buy rating on Rocket Pharmaceuticals (RCKT – Research Report) today. The company’s shares closed ...
Promising Phase 1 Trial Data and Market Potential Propel Buy Rating for Rocket Pharmaceuticals’ RP-A501 Gene Therapy
Jason Zemansky, an analyst from Bank of America Securities, reiterated the Buy rating on Rocket Pharmaceuticals (RCKT – Research Report). The ...
Lockheed Martin Just Lost a Multibillion-Dollar Deal -- but All Hope Is Not Lost
Lockheed Martin Just Lost a Multibillion-Dollar Deal -- but All Hope Is Not Lost was originally published by The Motley Fool ...
Biden ATACMS Decision Spurs Russian Threats, Hope and Derision Elsewhere
President-elect Donald Trump’s National Security Advisor nominee criticized the Biden administration for easing restrictions ...
Defence Web19h
Air Tractor Gaining Ground in Africa
AG Aviation is promoting the Air Tractor range for agriculture, firefighting, pest management (vector control), mining ...
MarketWatch23h
Rocket Cos. Inc.
Finance of America Cos. Inc. 27.51% $212.52M Finance of America Cos. Inc. Wt 525.00% ...